// App-Quantinova.ai

: Randomised Controlled Trial of Intravenous Iron (ferric carboxymaltose) for Second Trimester Anaemia in Malawian Pregnant Women (REVAMP)

Researchers

Presenter

  • Sant-Rayn Pasricha

Principal Investigators

  • Martin Mwangi

  • Ernest Moya

  • Ricardo Ataide

  • Glory Mzembe

  • Rebecca Harding

  • Truwah Zinenani

  • Danielle Clucas

  • Sabine Braat

  • Kamija S Phiri

Medical Centers

  • Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

  • Diagnostic Haematology, Royal Melbourne Hospital, Parkville, Australia

  • Walter and Eliza Hall Institute of Medical Research, Population Health and Immunity Division, Parkville, Australia

  • Department of Medical Biology, University of Melbourne, Parkville, Australia

  • Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia

  • Kamuzu University of Health Sciences (KUHeS), Training & Research Unit of Excellence (TRUE), Blantyre, Malawi

  • Clinical Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Parkville, Australia

  • Kamuzu University of Health Sciences (KUHeS), Training and Research Unit of Excellence, Blantyre, Malawi

  • Methods and Implementation Support for Clinical and Health Research Hub, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia

Locations

  • Australia

  • Malawi

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Obstetrics/Gynecology

  • Blood/haematological Diseases

Disease

  • Anemia

  • Spontaneous abortion

  • Malaria

Biomarkers

  • N/A

Drug/Treatment

  • Ferric carboxymaltose

  • Pyrimethamine

Outcome

  • N/A

Study Design

  • Randomized

  • Safety

  • Open Label

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved